Technology
Health
Biotechnology

Sinovac Biotech

$6.47
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) Today
$0.00 (0.00%) As of 3:00 PM EST after-hours

Why Robinhood?

You can watch SVA and buy or sell other stocks, options, ETFs, and crypto commission-free!

About SVA

Sinovac Biotech, Ltd. Ordinary Shares, also called Sinovac Biotech, is a holding company, which engages in the research, development, manufacture, and commercialization of vaccines that protect against human infectious diseases. Read More Its product portfolio includes vaccines against enterovirus71, or EV71, hepatitis A and B, seasonal influenza, H5N1 pandemic influenza, H1N1 influenza, and mumps. The company was founded in 1993 and is headquartered in Beijing, China.

Employees
735
Headquarters
Beijing, Beijing
Founded
1993
Market Cap
640.53M
Price-Earnings Ratio
18.50
Dividend Yield
Average Volume
0.00
High Today
Low Today
Open Price
Volume
0.00
52 Week High
$7.95
52 Week Low
$5.73

Collections

Technology
Health
Biotechnology
China
Asia

SVA Earnings

Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 28, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.